Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Z
Zaffaroni, Nadia
Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Nadia Zaffaroni
Favorite
Zahler, Stacey
Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Stacey Zahler
Favorite
Zaidi, Shane
The Royal Marsden Hospital
Paper 40 - PRIMARY CARDIAC AND GREAT VESSEL SARCOMAS: MULTI-MODALITY MANAGEMENT AND CLINICAL OUTCOMES AT THE ROYAL MARSDEN HOSPITAL 1987-2021
Shane Zaidi
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Shane Zaidi
Favorite
Zanframundo, Claudia
Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Claudia Zanframundo
Favorite
Zenke, Frank
EMD Serono Inc.
Paper 26 - NHEJ DEPENDENCE CREATES THERAPEUTIC VULNERABILITY IN LEIOMYOSARCOMA
Frank Zenke
Favorite
Zer, Alona
Session 3: Medical & Pediatric Oncology and Clinical Trials
Location: VCC, East Exhibition Hall A
Alona Zer
Favorite
Zeuner, Harald
F. Hoffmann-La Roche Ltd
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Harald Zeuner
Favorite
Zhao, Lili
University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Lili Zhao
Favorite
Zhou, Yifan
MD Anderson Cancer Center
Paper 88 - A NOVEL CD103+ CDC1 DENDRITIC CELL VACCINE FOR OSTEOSARCOMA
Yifan Zhou
Favorite
Zhu, Shirley
Stanford University
Paper 45 - MULTI-OMIC INTEGRATIVE PROFILING OF MINIGISTS AND CLINICALLY RELEVANT GISTS THROUGHOUT PROGRESSION
Shirley Zhu
Favorite
Ziegler, David
Children's Cancer Institute
Paper 27 - MULTI-PLATFORM TYROSINE KINASE PROFILING REVEALS NOVEL ACTIONABLE FGFR ABERRATIONS ACROSS PEDIATRIC AND ADOLESCENT AND YOUNG ADULT SARCOMAS
David Ziegler
Favorite
Zimmerman, Seth
Duke University School of Medicine
Paper 28 - CYCLIN DEPENDENT KINASE 8: A PHARMACOLOGIC TARGET FOR FUSION-POSITIVE RHABDOMYOSARCOMA
Seth Zimmerman
Favorite
Zwaan, Christian Michel
Prinses Maxima Centrum
Paper 24 - LONG-TERM EFFICACY AND SAFETY OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE FUSION SARCOMAS
Christian Michel Zwaan
Favorite
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Christian Michel Zwaan
Favorite
Zyczynski, Laurie
University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Laurie Zyczynski
Favorite
Back to Top
